Vanguard FTSE 100 UCITS GBP Inc is a equity ETF from Vanguard tracking the FTSE 100 index through physical replication. Domiciled in Ireland and launched in 2012, the fund manages about 5.4 bn € and charges a TER of 0.09% — 9 € per year on a €10,000 investment. Income is paid out to investors periodically (distributing).
Vanguard FTSE 100 UCITS GBP Inc competes with 11 other products on the same index (FTSE 100): it ranks 2nd by fund size and 5th by ongoing cost, with a TER of 0.09% against a group median of 0.09%. It has been listed since 2012, 14 years of track record.
On a €10,000 investment the TER costs 9 € a year. The cheapest of the group is Amundi FTSE 100 UCITS ETF EUR Hedged Acc at 0.05%, or 5 € on the same amount: a difference of 4 € every year, roughly 40 € over ten years before compounding.
Replication is physical: the fund holds the underlying securities directly. The ten largest positions account for 49.3% of the portfolio.
Income is distributed periodically: it produces cash flow, but reinvesting it is up to you if the goal is capital growth. The fund is denominated in GBP. That is not the same as currency risk: the exposure comes from the currencies of the underlying holdings, not from the denomination or the trading currency of a given listing.
The fund is domiciled in Ireland, which determines the tax treatment of income received by the fund and the supervisory authority.
| HSBC Holdings PLC | 9.8% |
| AstraZeneca PLC | 8.5% |
| Shell plc | 6.6% |
| Rolls-Royce Holdings PLC | 4.9% |
| Unilever PLC | 3.8% |
| British American Tobacco PLC | 3.8% |
| GSK plc | 3.2% |
| Rio Tinto PLC | 3.0% |
| BP PLC | 2.9% |
| Barclays PLC | 2.8% |
| Borsa Italiana | VUKE | EUR |
| XETRA | VUKE | EUR |
| Francoforte | VUKE | EUR |
| London Stock Exchange | VUKE | GBP |
| SIX Swiss Exchange | VUKE | CHF |
Source: the fund's KID and the issuer's official documentation — data verified as of July 2026.
This page is informational and is not an investment recommendation. Figures may contain errors or be out of date: always check the KID and the issuer's factsheet before any decision.